Cloning and expression of leishmania major superoxide dismutase b1: A potential target antigen for serodiagnosis of leishmaniasis

Iranian Journal of Immunology

Volumn 6, Issue 3, 2009, Pages 130-140

  Yeganeh, Farshid ^a   Barkhordari, Farzaneh ^b   Omidi, Maryam ^b   Samiei, Afshin ^a   Adeli, Ahmad ^b   Mahboudi, Fereidoon ^b   Kamali Sarvestani, Eskandar ^a,c  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; Elisa; Superoxide dismutase; Visceral leishmaniasis

Indexed keywords

ANTIGEN; RECOMBINANT SUPEROXIDE DISMUTASE B1 ANTIGEN; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; PARASITE ANTIGEN; PROTOZOON ANTIBODY;

ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; LEISHMANIA MAJOR; LMSODB1 GENE; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; SKIN LEISHMANIASIS; VISCERAL LEISHMANIASIS; AMINO ACID SEQUENCE; BIOSYNTHESIS; BLOOD; ENZYMOLOGY; GENETICS; IMMUNOLOGY; IRAN; METHODOLOGY; MOLECULAR CLONING; MOLECULAR GENETICS; PARASITOLOGY; SEQUENCE ALIGNMENT; SEROLOGY;

AMINO ACID SEQUENCE; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CLONING, MOLECULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IRAN; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MOLECULAR SEQUENCE DATA; SENSITIVITY AND SPECIFICITY; SEQUENCE ALIGNMENT; SEROLOGIC TESTS; SUPEROXIDE DISMUTASE;

EID: 74049135409     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. WHO. World Health Organization 2002. WHO information by topics or disease. Available at: http://www.who.int/leishmaniasis/burden/en/
2. Desjeux P. Leishmaniasis: current situation and new perspectives. Comp Immunol Microbiol Infect Dis. 2004; 27:305-18.
3. Weigle KA, Escobar M, Arias AL, Martinez F, Rojas C. A clinical prediction rule for American cutaneous leishmaniasis in Colombia. Int J Epidemiol. 1993; 22:548-58.
4. Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ. 2006; 333:723.
5. Schechter M, Flint JE, Voller A, Guhl F, Marinkelle CJ, Miles MA. Purified Trypanosoma cruzi specific glycoprotein for discriminative serological diagnosis of South American trypanosomiasis (Chagas' disease). Lancet. 1983; 2:939-41.
6. Burns JM Jr., Shreffler WG, Benson DR, Ghalib HW, Badaro R, Reed SG. Molecular characterization of a kinesin-related antigen of Leishmania chagasi that detects specific antibody in African and American visceral leishmaniasis. Proc Natl Acad Sci U S A. 1993; 90:775-9.
7. Braz RF, Nascimento ET, Martins DR, Wilson ME, Pearson RD, Reed SG, et al. The sensitivity and specificity of Leishmania chagasi recombinant K39 antigen in the diagnosis of American visceral leishmaniasis and in differentiating active from subclinical infection. Am J Trop Med Hyg. 2002; 67:344-8.
8. Pedras MJ, de Gouvea Viana L, de Oliveira EJ, Rabello A. Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis. Trans R Soc Trop Med Hyg. 2008; 102:172-8.
9. Jelinek T, Eichenlaub S, Loscher T. Sensitivity and specificity of a rapid immunochromatographic test for diagnosis of visceral leishmaniasis. Eur J Clin Microbiol Infect Dis. 1999; 18:669-70.
10. Diro E, Techane Y, Tefera T, Assefa Y, Kebede T, Genetu A, et al. Field evaluation of FD-DAT, rK39 dipstick and KATEX (urine latex agglutination) for diagnosis of visceral leishmaniasis in northwest Ethiopia. Trans R Soc Trop Med Hyg. 2007;101:908-14.
11. Locksley RM, Klebanoff SJ. Oxygen-dependent microbicidal systems of phagocytes and host defense against intracellular protozoa. J Cell Biochem. 1983;22:173-85.
12. Villagran ME, Marin C, Rodriguez-Gonzalez I, De Diego JA, Sanchez-Moreno M. Use of an iron superoxide dismutase excreted by Trypanosoma cruzi in the diagnosis of Chagas disease: seroprevalence in rural zones of the state of Queretaro, Mexico. Am J Trop Med Hyg. 2005;73:510-6.
13. Marin C, Longoni SS, Urbano J, Minaya G, Mateo H, de Diego JA, et al. Enzyme-linked immunosorbent assay for superoxide dismutase-excreted antigen in diagnosis of sylvatic and Andean cutaneous leishmaniasis of Peru. Am J Trop Med Hyg. 2009;80:55-60.
14. Marin C, Longoni SS, Mateo H, de Diego JA, Alunda JM, Minaya G, et al. The use of an excreted superoxide dismutase in an ELISA and Western blotting for the diagnosis of Leishmania (Leishmania) infantum naturally infected dogs. Parasitol Res. 2007;101:801-8.
15. Kelly JM. Isolation of DNA and RNA from Leishmania. Methods Mol Biol. 1993;21:123-31.
16. Ivens AC, Peacock CS, Worthey EA, Murphy L, Aggarwal G, Berriman M, et al. The genome of the kinetoplastid parasite, Leishmania major. Science. 2005;309:436-42.
17. Mojtahedi Z, Clos J, Kamali-Sarvestani E. Leishmania major: identification of developmentally regulated proteins in procyclic and metacyclic promastigotes. Exp Parasitol. 2008;119:422-9.
18. Farajnia S, Darbani B, Babaei H, Alimohammadian MH, Mahboudi F, Gavgani AM. Development and evaluation of Leishmania infantum rK26 ELISA for serodiagnosis of visceral leishmaniasis in Iran. Parasitology. 2008;135:1035-41.
19. Maalej IA, Chenik M, Louzir H, Ben Salah A, Bahloul C, Amri F, et al. Comparative evaluation of ELISAs based on ten recombinant or purified Leishmania antigens for the serodiagnosis of Mediterranean visceral leishmaniasis. Am J Trop Med Hyg. 2003;68:312-20.
20. Boarino A, Scalone A, Gradoni L, Ferroglio E, Vitale F, Zanatta R, et al. Development of recombinant chimeric antigen ex- pressing immunodominant B epitopes of Leishmania infantum for serodiagnosis of visceral leishmaniasis. Clin Diagn Lab Immunol. 2005;12:647-53.
21. Sundar S, Singh RK, Bimal SK, Gidwani K, Mishra A, Maurya R, et al. Comparative evaluation of parasitology and serologi- cal tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy study. Trop Med Int Health. 2007;12:284-9.
22. Chiller TM, Samudio MA, Zoulek G. IgG antibody reactivity with Trypanosoma cruzi and Leishmania antigens in sera of patients with Chagas' disease and leishmaniasis. Am J Trop Med Hyg. 1990;43:650-6.
23. Mikaeili F, Fakhar M, Sarkari B, Motazedian MH, Hatam G. Comparison of serological methods (ELISA, DAT and IFA) for diagnosis of visceral leishmaniasis utilizing an endemic strain. Iran J Immunol. 2007;4:116-21.
24. dos Santos JI, Morgado MG, Galvao-Castro B. Human visceral leishmaniasis: analysis of the specificity of humoral immune response to polypeptides of Leishmania donovani chagasi. Am J Trop Med Hyg. 1987;37:263-70.
25. Zeyrek FY, Korkmaz M, Ozbel Y. Serodiagnosis of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica in Sanliurfa Province, Turkey, where ACL Is highly endemic. Clin Vaccine Immunol. 2007;14:1409-15.
26. Alborzi A, Pourabbas B, Shahian F, Mardaneh J, Pouladfar GR, Ziyaeyan M. Detection of Leishmania infantum kinetoplast DNA in the whole blood of asymptomatic individuals by PCR-ELISA and comparison with other infection markers in en- demic areas, southern Iran. Am J Trop Med Hyg. 2008;79:839-42.
27. Elkon K, Skelly S, Parnassa A, Moller W, Danho W, Weissbach H, et al. Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci U S A. 1986;83:7419-23.
28. Elkon K, Bonfa E, Llovet R, Danho W, Weissbach H, Brot N. Properties of the ribosomal P2 protein autoantigen are similar to those of foreign protein antigens. Proc Natl Acad Sci U S A. 1988;85:5186-9.
29. Sundar S, Singh RK, Maurya R, Kumar B, Chhabra A, Singh V, et al. Serological diagnosis of Indian visceral leishmaniasis: direct agglutination test versus rK39 strip test. Trans R Soc Trop Med Hyg. 2006;100:533-7.
30. Ritmeijer K, Melaku Y, Mueller M, Kipngetich S, O'Keeffe C, Davidson RN. Evaluation of a new recombinant K39 rapid diagnostic test for Sudanese visceral leishmaniasis. Am J Trop Med Hyg. 2006;74:76-80.